Precigen Inc is a biotechnology company that develops synthetic biology solutions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PGEN is expected to report earnings to fall 32.16% to -5 cents per share on May 07
Q1'25
Est.
$-0.05
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.13
Q1'24
Missed
by $0.01
The last earnings report on March 19 showed earnings per share of -7 cents, missing the estimate of -6 cents. With 827.66K shares outstanding, the current market capitalization sits at 467.53M.